Shukra Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
442.39 Cr.
|
P/BV
|
10.00
|
Book Value (Rs.)
|
10.11
|
52 Week High/Low (Rs.)
|
101/20
|
FV/ML
|
10/1
|
P/E(X)
|
100.43
|
Bookclosure
|
20/04/2024
|
EPS (Rs.)
|
1.01
|
Div Yield (%)
|
0.49
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 26.21 | 4.79 | 0.22 | 0.23 | 2.95 |
Diluted EPS (Rs.) | 26.21 | 4.79 | 0.22 | 0.23 | 2.95 |
Cash EPS (Rs.) | 15.95 | 15.41 | 9.63 | 9.67 | 9.10 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 64.63 | 104.43 | 99.63 | 98.43 | 98.20 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 64.63 | 104.43 | 99.63 | 98.43 | 98.20 |
Dividend / Share (Rs.) | 0.50 | 0.50 | 0.00 | 0.00 | 0.50 |
Revenue From Operations / Share (Rs.) | 150.31 | 130.84 | 71.51 | 75.66 | 36.15 |
PBDIT / Share (Rs.) | 16.76 | 18.95 | 11.50 | 9.90 | 10.78 |
PBIT / Share (Rs.) | 12.07 | 8.33 | 2.09 | 0.45 | 4.63 |
PBT / Share (Rs.) | 11.35 | 6.50 | 0.62 | 0.43 | 4.63 |
Net Profit / Share (Rs.) | 11.26 | 4.79 | 0.21 | 0.22 | 2.95 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 11.15 | 14.48 | 16.07 | 13.08 | 29.81 |
PBIT Margin (%) | 8.02 | 6.36 | 2.91 | 0.60 | 12.80 |
PBT Margin (%) | 7.54 | 4.96 | 0.87 | 0.57 | 12.79 |
Net Profit Margin (%) | 7.48 | 3.66 | 0.30 | 0.30 | 8.16 |
Return on Networth / Equity (%) | 17.41 | 4.59 | 0.21 | 0.23 | 3.00 |
Return on Capital Employeed (%) | 14.54 | 5.73 | 1.14 | 0.27 | 2.97 |
Return On Assets (%) | 5.87 | 2.13 | 0.09 | 0.10 | 1.62 |
Long Term Debt / Equity (X) | 0.14 | 0.19 | 0.62 | 0.52 | 0.39 |
Total Debt / Equity (X) | 0.20 | 0.20 | 0.62 | 0.52 | 0.39 |
Asset Turnover Ratio (%) | 1.07 | 0.58 | 0.32 | 0.38 | 0.21 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.25 | 1.27 | 2.46 | 2.07 | 2.77 |
Quick Ratio (X) | 1.17 | 0.94 | 2.19 | 1.87 | 2.70 |
Inventory Turnover Ratio (X) | 3.19 | 3.93 | 1.93 | 4.02 | 5.57 |
Dividend Payout Ratio (NP) (%) | 1.77 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Payout Ratio (CP) (%) | 1.25 | 0.00 | 0.00 | 0.00 | 0.00 |
Earning Retention Ratio (%) | 98.23 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash Earning Retention Ratio (%) | 98.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 23.36 | 10.35 | 54.07 | 753.22 | 2715.04 |
Interest Coverage Ratio (Post Tax) (%) | 16.69 | 3.62 | 7.88 | -30.79 | 744.19 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 19.48 | 12.75 | 16.23 | 15.24 | 11.53 |
EV / Net Operating Revenue (X) | 0.33 | 0.62 | 1.45 | 1.29 | 2.04 |
EV / EBITDA (X) | 2.97 | 4.30 | 9.02 | 9.84 | 6.83 |
MarketCap / Net Operating Revenue (X) | 0.31 | 0.46 | 0.62 | 0.61 | 1.01 |
Retention Ratios (%) | 98.22 | 0.00 | 0.00 | 0.00 | 0.00 |
Price / BV (X) | 0.72 | 0.57 | 0.44 | 0.47 | 0.37 |
Price / Net Operating Revenue (X) | 0.31 | 0.46 | 0.62 | 0.61 | 1.01 |
EarningsYield | 0.23 | 0.07 | 0.00 | 0.00 | 0.08 |